SOURCE: Facet Biotech Corporation

Facet Biotech Corporation

September 02, 2009 16:15 ET

Facet Biotech Announces Participation at Upcoming Investor Conferences

REDWOOD CITY, CA--(Marketwire - September 2, 2009) - Facet Biotech Corporation (NASDAQ: FACT) today announced that the company will participate at upcoming investor conferences. These conferences include:

--  The Thomas Weisel Partners Healthcare Conference in Boston on
    Thursday, September 10, 2009 at 4:25 p.m., Eastern Time.
--  The UBS Global Life Sciences Conference in New York on Wednesday,
    September 23, 2009 at 8:30 a.m., Eastern Time.

Live webcasts of both presentations will be available through the Facet website at Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. A replay will be available at starting approximately one hour after completion of the webcast.

About Facet Biotech

Facet Biotech is a biotechnology company dedicated to advancing its pipeline of five clinical-stage products, leveraging its research and development capabilities to identify and develop new oncology drugs and applying its proprietary next-generation protein engineering technologies to potentially improve the clinical performance of protein therapeutics. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.

NOTE: Facet Biotech and the Facet Biotech logo are considered trademarks of Facet Biotech Corporation.

Contact Information